Tilray Inc (TLRY) - Cash Flow Conversion Efficiency

Latest as of February 2026: -0.014x

Based on the latest financial reports, Tilray Inc (TLRY) has a cash flow conversion efficiency ratio of -0.014x as of February 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-21.94 Million ≈ $-15.87 Million USD) by net assets (CA$1.53 Billion ≈ $1.10 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see TLRY market cap for the company's overall valuation and market capitalisation.

Tilray Inc - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Tilray Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Tilray Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tilray Inc ranked by their cash flow conversion efficiency. Explore Tilray Inc earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Zhejiang Sunrise Garment Group Co Ltd SHG:605138	N/A
Longjian Road & Bridge Co Ltd SHG:600853	0.111x
Haypp Grp Ab ST:HAYPP	0.035x
Sampoerna Agro Tbk JK:SGRO	0.034x
EQV Ventures Acquisition Corp. II NYSE:EVAC	0.007x
Nanhua Bio Medicine Co Ltd SHE:000504	0.062x
Metrogas SA BA:METR	0.029x
Zhejiang Talent Television&Film Co Ltd SHE:300426	-0.598x

Annual Cash Flow Conversion Efficiency for Tilray Inc (2012–2025)

The table below shows the annual cash flow conversion efficiency of Tilray Inc from 2012 to 2025. View TLRY stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-05-31	CA$1.49 Billion ≈ $1.08 Billion	CA$-94.60 Million ≈ $-68.43 Million	-0.064x	-607.55%
2024-05-31	CA$3.44 Billion ≈ $2.49 Billion	CA$-30.91 Million ≈ $-22.36 Million	-0.009x	-478.05%
2023-05-31	CA$3.33 Billion ≈ $2.41 Billion	CA$7.91 Million ≈ $5.72 Million	0.002x	+105.95%
2022-05-31	CA$4.44 Billion ≈ $3.21 Billion	CA$-177.26 Million ≈ $-128.23 Million	-0.040x	-298.55%
2021-05-31	CA$4.47 Billion ≈ $3.23 Billion	CA$-44.72 Million ≈ $-32.35 Million	-0.010x	+86.24%
2020-05-31	CA$1.33 Billion ≈ $958.73 Million	CA$-96.43 Million ≈ $-69.76 Million	-0.073x	-126.78%
2019-05-31	CA$1.28 Billion ≈ $926.63 Million	CA$-41.10 Million ≈ $-29.73 Million	-0.032x	-566.53%
2018-05-31	CA$910.14 Million ≈ $658.38 Million	CA$-4.38 Million ≈ $-3.17 Million	-0.005x	-124.75%
2017-05-31	CA$203.29 Million ≈ $147.06 Million	CA$3.95 Million ≈ $2.86 Million	0.019x	+168.90%
2016-05-31	CA$26.85 Million ≈ $19.42 Million	CA$-757.62K ≈ $-548.05K	-0.028x	+93.08%
2015-05-31	CA$10.74 Million ≈ $7.77 Million	CA$-4.38 Million ≈ $-3.17 Million	-0.408x	-169.35%
2014-05-31	CA$271.84K ≈ $196.64K	CA$-41.16K ≈ $-29.78K	-0.151x	0.00%
2013-05-31	CA$271.84K ≈ $196.64K	CA$-41.16K ≈ $-29.78K	-0.151x	-17.18%
2012-05-31	CA$333.15K ≈ $241.00K	CA$-43.05K ≈ $-31.14K	-0.129x	--

About Tilray Inc

TO:TLRY Canada Drug Manufacturers - Specialty & Generic

Market Cap

$483.65 Million

CA$668.59 Million CAD

Market Cap Rank

#12526 Global

#364 in Canada

Share Price

CA$5.59

Change (1 day)

+1.45%

52-Week Range

CA$1.15 - CA$19.12

All Time High

CA$26.00